JPM KRAS G12C deep dive ahead of #ASCO20  - Data comparison of $AMGN sotorasib (AMG 510) vs $MX MX849 - Other key players in clinical development: $JNJ / Wellspring, $LLY and Boehringer Ingelheim - Estimated TAM ceiling of $5.5B in KRAS G12C+ #NSCLC